CARCINOGENIC RISK OF IRON-DEXTRAN.
作者信息
GIUFFRIDA G, CONDORELLI M, FILOCAMO G, MIGLIAU G, PUGLIESE F, BASILE U
出版信息
Br Med J. 1964 Jun 20;1(5398):1583-4. doi: 10.1136/bmj.1.5398.1583.
Abstract
摘要
相似文献
1
CARCINOGENIC RISK OF IRON-DEXTRAN.
Br Med J. 1964 Jun 20;1(5398):1583-4. doi: 10.1136/bmj.1.5398.1583.
2
MORPHOLOGICAL EFFECTS OF IRON-DEXTRAN ON FOWL FIBROCYTES IN VITRO.
Br J Cancer. 1963 Dec;17(4):731-7. doi: 10.1038/bjc.1963.94.
3
CARCINOGENIC risks of iron-dextran.
Br Med J. 1960 Mar 12;1(5175):788-9.
4
[Research on the in vivo carcinogenic activity of an iron-dextran complex in the rat].
C R Seances Soc Biol Fil. 1962;156:691-3.
5
IRON-DEXTRAN CARCINOGENESIS IN RATS: EFFECT OF DISTRIBUTING INJECTED MATERIAL BETWEEN ONE, TWO, FOUR, OR SIX SITES.
Br J Cancer. 1964 Dec;18(4):801-8. doi: 10.1038/bjc.1964.93.
6
INDUCTION OF SARCOMATA IN RABBITS BY INTRAMUSCULAR INJECTION OF IRON-DEXTRAN ("IMFERON").
Br Med J. 1964 Jun 20;1(5398):1593-4. doi: 10.1136/bmj.1.5398.1588.
7
[THE TOLERANCE OF IRON THERAPY WITH SPECIAL REFERENCE TO THE CARCINOGENIC EFFECT OF THE DEXTRAN-IRON COMPLEX].
Med Welt. 1964 Feb 8;6:277-82.
8
The carcinogenicity of an iron-dextran complex.
Cancer Prog. 1960:24-33.
9
[Current knowledge of the presumed carcinogenic power of the iron-dextran complex (Imferon)].
Rev Obstet Ginecol Venez. 1961;21:307-13.
10
THE RISK OF SARCOMATOUS CHANGE AFTER IRON-DEXTRAN THERAPY.
Indian J Pediatr. 1965 Feb;32:75-7.
本文引用的文献
1
The tissue response to iron-dextran; an electron-microscope study.
J Pathol Bacteriol. 1961 Oct;82:471-82.
2
NATURAL, METALLIC AND OTHER SUBSTANCES, AS CARCINOGENS.
Br Med Bull. 1964 May;20:127-33. doi: 10.1093/oxfordjournals.bmb.a070305.
3
On the carcinogenicity of an iron-dextran complex.
J Natl Cancer Inst. 1960 Jan;24:109-47.
Zotero 插件